(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

PICOVIR

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

PICOVIR

ST13

US500000087023159

Class

5

Filing

87023159

Registration

6119173

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

47

Latest update

08/05/2025

Trademark type

Word

Nice classes

5

Filing date

05/03/2016

Registration date

08/04/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/04/2020

Last transaction

08/05/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

10/31/2019

First use in commerce

10/31/2019

Drawing code

4

Owner type

03

Owner location

Princeton Junction, NJ

Examiner

FATHY, DOMINIC

Law office

L40

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

AntiVirus Therapeutics, Inc.
AntiVirus Therapeutics, Inc.

Representatives

Sima Singadia Kulkarni DLA Piper LLP (US)

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

AntiviralsPharmaceutical preparations for the treatment of infectious diseasesPharmaceutical preparations for the treatment and prevention of infectious diseasesPharmaceutical preparations for the treatment of sepsisPharmaceutical preparations for the prevention and treatment of disorders of the nervous systemthe immune systemthe cardio-vascular systemthe metabolic systemthe respiratory systemthe musculo-skeletal systemthe genitourinary system; Pharmaceutical preparations for the treatment of inflammatory disorders; Pharmaceutical preparations for use in dermatologyoncologyhematology and in tissue and organ transplantationin ophthalmology and for gastroenterological disordersPharmaceutical preparationsantiviralsPharmaceutical preparations for the treatment of picornavirusenterovirusrhinovirus infectionPharmaceutical preparations for the treatment of neonatal enteroviral sepsis

Publications

History of USPTO decisions and trademark events.

47 publications found

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

08/04/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

08/04/2020

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

06/30/2020

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

06/29/2020

SUPC

STATEMENT OF USE PROCESSING COMPLETE

06/10/2020

IUAF

USE AMENDMENT FILED

06/08/2020

EISU

TEAS STATEMENT OF USE RECEIVED

06/08/2020

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

12/06/2019

EX5G

SOU EXTENSION 5 GRANTED

12/05/2019

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

12/05/2019

EXT5

SOU EXTENSION 5 FILED

12/03/2019

EEXT

SOU TEAS EXTENSION RECEIVED

12/03/2019

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

06/04/2019

EX4G

SOU EXTENSION 4 GRANTED

05/31/2019

EXT4

SOU EXTENSION 4 FILED

05/31/2019

EEXT

SOU TEAS EXTENSION RECEIVED

05/31/2019

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

12/08/2018

EX3G

SOU EXTENSION 3 GRANTED

12/06/2018

EXT3

SOU EXTENSION 3 FILED

12/06/2018

EEXT

SOU TEAS EXTENSION RECEIVED

12/06/2018

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

05/31/2018

EX2G

SOU EXTENSION 2 GRANTED

05/29/2018

EXT2

SOU EXTENSION 2 FILED

05/29/2018

EEXT

SOU TEAS EXTENSION RECEIVED

05/29/2018

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

12/07/2017

EX1G

SOU EXTENSION 1 GRANTED

12/05/2017

EXT1

SOU EXTENSION 1 FILED

12/05/2017

EEXT

SOU TEAS EXTENSION RECEIVED

12/05/2017

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/26/2017

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/26/2017

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

06/06/2017

ETOP

EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED

04/27/2017

ETOF

EXTENSION OF TIME TO OPPOSE RECEIVED

11/04/2016

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/18/2016

PUBO

PUBLISHED FOR OPPOSITION

10/18/2016

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/28/2016

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/22/2016

XAEC

EXAMINER'S AMENDMENT ENTERED

08/22/2016

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

08/22/2016

GNEA

EXAMINERS AMENDMENT E-MAILED

08/22/2016

CNEA

EXAMINERS AMENDMENT -WRITTEN

08/22/2016

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

08/20/2016

GNRT

NON-FINAL ACTION E-MAILED

08/20/2016

CNRT

NON-FINAL ACTION WRITTEN

08/20/2016

DOCK

ASSIGNED TO EXAMINER

08/18/2016

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/06/2016

NWAP

NEW APPLICATION ENTERED

05/06/2016

Continuous trademark protection

Get notified about every new filing that threatens PICOVIR or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.